★ Sign in to follow
JB

Julie Brogren

Executive
SE·Finansinspektionen
Ascelia Pharma AB
Total declarations
20
Company
1
▲ Purchases (9 ops.)
€128k
▼ Sales (0 ops.)
—

Latest filing published 21 Apr 2025 for Ascelia Pharma AB.

Filing timeline

BuySale
Julie Brogren

Insider track record

Disclosed buys
9
Disclosed sells
0
Signal history

Closed purchases

Market purchases
9

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Julie Brogren: trading record in brief

Julie Brogren is a declared insider of Ascelia Pharma AB, with filings sourced from Finansinspektionen. Over a trading history stretching from 17 August 2020 to 15 April 2025, the count stands at 20 filings.

Purchases make up the whole of the open-market record (9 purchases, €128k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants.

Half of the purchases are above €14k and half below.

Most recently, on 21 April 2025, the filings show a transaction in Ascelia Pharma AB. The most recent open-market purchase was published on 8 January 2024, 1,035 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Julie Brogren

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ●
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    0FI-SE
    18,000 shares0TeckningsoptionISIN SE0022725438FI:csv-b649c5fd1ee341ef7517
  • ●
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    38,700 SEK24FI-SE
    18,000 shares@ SEK 2.1515.8% of flowAktieISIN SE0010573113FI:csv-3ba08fc82ebbbcb82385
  • ◆
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    0FI-SE
    825,000 shares0OptionFI:csv-22396e7f9fa8446f9327
  • ◆
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    0FI-SE
    7,770 shares0AktieISIN SE0010573113FI:csv-25538a1dd1a741a1c906
  • ●
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    0FI-SE
    53,989 shares0Teckningsrätt/UniträttISIN SE0022725453FI:csv-c7007a7d6e200f9e900e
  • ●
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    0FI-SE
    10,114 shares0Teckningsrätt/UniträttISIN SE0022725453FI:csv-b54bab7cee45cde9ece6
  • ●
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    168,446 SEK0FI-SE
    33,224 shares@ SEK 5.0741.0% of flowBTU (betald tecknad unit)ISIN SE0022725461FI:csv-e06d2e23bbd15af34e79
  • ●
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    31,556 SEK0FI-SE
    6,224 shares@ SEK 5.077.7% of flowBTU (betald tecknad unit)ISIN SE0022725461FI:csv-f43c1b89efbcceb10dfb
  • ●
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    0FI-SE
    54,000 shares0Teckningsrätt/UniträttISIN SE0022725453FI:csv-a62869deef54e70af21a
  • ▲
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    169,500 SEK38FI-SE
    30,000 shares@ SEK 5.6541.8% of flowAktieISIN SE0010573113FI:csv-ed452941c3370d47edd3
    Canonical exit: 7 Apr 2024 (T+90)
  • ◆
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    0FI-SE
    12,000 shares0AktieISIN SE0010573113FI:csv-fba846a8eaddfc7cf73f
  • ◆
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    0FI-SE
    300,000 shares0OptionFI:csv-1129d0f278b4b1e2eee8
  • ▲
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    41,246 SEK23FI-SE
    10,060 shares@ SEK 4.109.6% of flowAktieISIN SE0010573113FI:csv-071a8f0ab33e1c1a560f
    Canonical exit: 18 Dec 2023 (T+90)
  • ▲
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    3,317 SEK0FI-SE
    240 shares@ SEK 13.82AktieISIN SE0010573113FI:csv-4ba58a24fc4c8d173d43
    Canonical exit: 11 Oct 2023 (T+90)
  • ▲
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    142,346 SEK0FI-SE
    10,300 shares@ SEK 13.82AktieISIN SE0010573113FI:csv-1a061b158f12b0683e4b
    Canonical exit: 11 Oct 2023 (T+90)
  • ▲
    Julie Brogren
    Vice VDExecutivesAscelia Pharma AB
    111,160 SEK0FI-SE
    7,000 shares@ SEK 15.88AktieISIN SE0010573113FI:csv-76ae681b524f17106e19
    Canonical exit: 9 Mar 2023 (T+90)
  • ▲
    Julie Brogren
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesAscelia Pharma AB
    309,600 SEK0FI-SE
    15,000 shares@ SEK 20.64AktieISIN SE0010573113FI:csv-3688a9e6faf61ebc37b1
    Canonical exit: 1 Sept 2022 (T+90)
  • ▲
    Julie Brogren
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesAscelia Pharma AB
    208,250 SEK0FI-SE
    7,000 shares@ SEK 29.75AktieISIN SE0010573113FI:csv-9c87333b994f8444f8d1
    Canonical exit: 16 Dec 2021 (T+90)
  • ▲
    Julie Brogren
    Chief Commercial OfficerExecutivesAscelia Pharma AB
    233,400 SEK0FI-SE
    6,000 shares@ SEK 38.90AktieISIN SE0010573113FI:csv-021cefd5630fd122a9a4
    Canonical exit: 23 Dec 2020 (T+90)
  • ▲
    Julie Brogren
    CCOExecutivesAscelia Pharma AB
    149,392 SEK0FI-SE
    6,000 shares@ SEK 24.8987AktieISIN SE0010573113FI:csv-119888247ac5ba611418
    Canonical exit: 15 Nov 2020 (T+90)

20 of 20 declarations

Related entities

No related entities found.